Live feed17:36:44·1491dINSIDERFilingvia QuantisnowSEC Form 4: Valliant John sold $2,256 worth of shares (300 units at $7.52) as part of a pre-agreed trading plan, decreasing direct ownership by 0.08% to 366,960 unitsByQuantisnow·Wall Street's wire, on your screen.FUSN· Fusion Pharmaceuticals Inc.Health CareOriginal source